梅州四十天可以做流产吗梅州人流危险大吗,梅州激光治疗宫颈炎,梅州滴虫性阴道炎应该如何医治,梅州可以做人流医院,梅州哪家医院妇科正规,梅州哪家医院做无痛打胎好,梅州哪里有好的妇科病医院

BEIJING, Nov. 27 (Xinhua) -- A government official on Sunday refuted an accusation that discriminations widely exist in the country's civil service recruitment process.Nie Shengkui, director of the examination and recruitment department of the State Administration of Civil Service (SACS), said that the recruitment process is always based on the principles of justice and fairness, which has promoted the upward mobility of people from the grassroots.The ratio of recruited male and female applicants is around 6 to 4 in last year, equal to the ratio of the male and female applicants, and more than 92 percent of the recruited are from the ordinary families in the grassroots, including 29 percent from the rural areas, according to Nie.Nie's words came after a survey report published earlier last week, accusing the authorities of having discriminatory requirements in civil servants recruitment.Conducted by the Constitutionalism Research Institute of China University of Political Science and Law, the survey report said that without publicly acknowledging any form of discrimination, many public offices don't hesitate to hide their preferences on age, gender, education and state of health in recruitment.Nie defended that it is necessary to set some requirements in the recruitment in a bid to guarantee the future civil servants can carry out there duty competently."Civil servants recruitment is a process of choosing talents for the government to manage the country, not for promoting employment," said Nie, "so there is nothing to do with employment discriminations."Chinese college grads are usually enthusiast about finding jobs within government branches, especially at a time when people are trying to secure a stable future amid a troubled global economy.A total of 970,000 applicants took the general exam of the recruitment on Saturday and Sunday, They will compete for only 18,000 posts in central government departments and their local branches.

SAN FRANCISCO, Dec. 2 (Xinhua) -- Only two weeks after its shipment, Amazon's Kindle Fire has already shown the momentum to grab the second place in global tablet computer market, research firm IHS predicted on Friday.Amazon is expected to ship 3.9 million Kindle Fire tablets during the last three months of 2011, the first quarter the product goes on sale, according to preliminary projection from IHS.The number will give Amazon a 13.8-percent share of global tablet market in the fourth quarter, surpassing the 4.8 percent held by No. 3 player Samsung, and second only to Apple's commanding 65.6 percent market share."Nearly two years after Apple Inc. rolled out the iPad, a competitor has finally developed an alternative which looks like it might have enough of Apple's secret sauce to succeed," Rhoda Alexander, senior manager of tablet and monitor research for IHS, said in a statement."Initial market response strongly suggests that Amazon, with the Kindle Fire, has found the right combination of savvy pricing, astute marketing, accessible content and an appropriate business model, positioning the Kindle Fire to appeal to a brand-new set of media tablet buyers," she added.IHS analysts noted that with a price tag of 199 U.S. dollars, the Kindle Fire has set a new bar for pricing, bringing the tablet within reach of a larger portion of the buying public.IHS expects Kindle Fire's rapid ascent to help fuel the expansion of the entire tablet market, now predicting that 64.7 million tablets will be shipped in 2011, higher than its previous forecast of 60 million issued in August.The total tablet shipment number this year will represent a 273- percent growth from 17.4 million units in 2010, said IHS, which has also increased its longer-term projection of global tablet shipment in 2015 to 287.2 million units.

WASHINGTON, Dec. 22 (Xinhua) -- The journal Science on Thursday chose the HPTN 052 clinical trial, an international HIV prevention trial as the 2011 Breakthrough of the Year.The study found that if HIV-infected heterosexual individuals begin taking anti-retroviral medicines when their immune systems are relatively healthy as opposed to delaying therapy until the disease has advanced, they are 96 percent less likely to transmit the virus to their uninfected partners. Findings from the trial, first announced in May, were published in the New England Journal of Medicine in August.The study was funded by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health."The HPTN 052 study convincingly demonstrated that anti- retroviral medications can not only treat but also prevent the transmission of HIV infection among heterosexual individuals," said NIAID Director Anthony Fauci in a statement. "We are pleased that Science recognized the extraordinary public health significance of these study results."Science's list of nine other ground-breaking scientific achievements from 2011 include:The Hayabusa Mission: After some near-disastrous technical difficulties and a stunningly successful recovery, Japan's Hayabusa spacecraft returned to Earth with dust from the surface of a large, S-type asteroid. This asteroid dust represented the first direct sampling of a planetary body in 35 years, and analysis of the grains confirmed that the most common meteorites found on Earth, known as ordinary chondrules, are born from these much larger, S-type asteroids.Unraveling Human Origins: Studying the genetic code of both ancient and modern human beings, researchers discovered that many humans still carry DNA variants inherited from archaic humans, such as the mysterious Denisovans in Asia and still-unidentified ancestors in Africa. One study this year revealed how archaic humans likely shaped our modern immune systems, and an analysis of Australopithecus sediba fossils in South Africa showed that the ancient hominin possessed both primitive and Homo-like traits.Capturing a Photosynthetic Protein: In vivid detail, researchers in Japan have mapped the structure of the Photosystem II, or PSII, protein that plants use to split water into hydrogen and oxygen atoms. The crystal-clear image shows off the protein's catalytic core and reveals the specific orientation of atoms within. Now, scientists have access to this catalytic structure that is essential for life on Earth -- one that may also hold the key to a powerful source of clean energy.Pristine Gas in Space: Astronomers using the Keck telescope in Hawaii to probe the faraway universe wound up discovering two clouds of hydrogen gas that seem to have maintained their original chemistry for two billion years after the big bang. Other researchers identified a star that is almost completely devoid of metals, just as the universe's earliest stars must have been, but that formed much later. The discoveries show that pockets of matter persisted unscathed amid eons of cosmic violence.

WASHINGTON, Oct. 19 (Xinhua) -- A total of 25 people have been killed in 12 U.S. states in a listeria outbreak traced to Colorado cantaloupes, the U.S. Centers for Disease Control and Prevention ( CDC) said Wednesday.The number of people sickened by the tainted cantaloupes has reached 123 in 26 states, with Pennsylvania reporting its first case. One of the ill patients, a pregnant woman, suffered a miscarriage, the CDC said in a telebriefing.The listeria outbreak has been the most deadly one since 1998, according to the CDC.Listeria is a common bacterium that typically causes mild illness in healthy people, but can cause severe illness in older people and those with compromised immune systems. It also can cause miscarriages and stillbirths in pregnant women and severe infections in new babies.The CDC estimates that about 48 million people in the U.S. each year get sick from tainted food, with about 128,000 hospitalized and 3,000 deaths.

WASHINGTON, Nov. 11 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved HEMACORD, the first licensed hematopoietic progenitor cells-cord cell therapy.HEMACORD is indicated for use in hematopoietic stem cell transplantation procedures in patients with disorders affecting the blood forming system. For example, cord blood transplants have been used to treat patients with certain blood cancers and some inherited metabolic and immune system disorders."The use of cord blood hematopoietic progenitor cell therapy offers potentially life-saving treatment options for patients with these types of disorders," said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement.HEMACORD contains hematopoietic progenitor cells (HPCs) from human cord blood. Cord blood is one of three sources of HPCs used in transplants. The other two are bone marrow and peripheral blood. Once these HPCs are infused into patients, the cells migrate to the bone marrow where they divide and mature. When the mature cells move into the bloodstream they can partially or fully restore the number and function of many blood cells, including immune function.